Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
11.75
0.37 (3.25%)
At close: Aug 15, 2025, 3:50 PM
11.60
-1.28%
After-hours: Aug 15, 2025, 05:26 PM EDT

Pharming Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.49M -12.01M 14.99M 22.03M
Depreciation & Amortization
15.51M 15.93M 13.19M 18.72M
Stock-Based Compensation
10.86M 9.25M 6.39M 9.06M
Other Working Capital
-2.79M 14.27M 14.63M 1.14M
Other Non-Cash Items
-10.55M -13.51M -11.28M -7.82M
Deferred Income Tax
n/a n/a n/a -721.22K
Change in Working Capital
-10.07M -16.96M -387K -4.73M
Operating Cash Flow
-1.79M -17.3M 22.9M 36.13M
Capital Expenditures
-796K -1.46M -1.98M -15.96M
Cash Acquisitions
n/a n/a 7.3M n/a
Purchase of Investments
-284.31M -382.01M n/a -4.38M
Sales Maturities Of Investments
316.73M 232.81M n/a n/a
Other Investing Acitivies
n/a 21.28M 6.26M -0.00
Investing Cash Flow
31.62M -129.39M 5.32M -20.34M
Debt Repayment
-34.39M -4.64M -3.09M -2.83M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-19K 3.6M -4.17M -29.84M
Financial Cash Flow
-34.41M -1.04M -4.98M -26.68M
Net Cash Flow
-6.8M -145.6M 15.42M 2.57M
Free Cash Flow
-2.59M -18.77M 20.92M 20.17M